Senti Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.8%.

Top 25 shareholders own 47.6% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.9%	Bayer Aktiengesellschaft	5,878,488	US$1.7m	0%	no data
9.67%	New Enterprise Associates, Inc.	4,426,151	US$1.2m	0%	0.08%
5.55%	8VC	2,537,558	US$712.8k	0%	0.8%
4.26%	Omid Farokhzad	1,947,403	US$547.0k	0%	no data
3.56%	ARK Investment Management LLC	1,630,922	US$458.1k	-17.2%	no data
3.53%	Timothy Lu	1,616,276	US$454.0k	0%	no data
2.05%	Philip Lee	936,424	US$263.0k	0%	no data
1.55%	The Vanguard Group, Inc.	707,052	US$198.6k	27.8%	no data
1.3%	Intel Capital Corporation	595,665	US$167.3k	0%	0.03%
0.68%	Triatomic Management LP	310,533	US$87.2k	0%	0.8%
0.52%	Geode Capital Management, LLC	238,406	US$67.0k	0%	no data
0.43%	Omega Fund Management, LLC	195,792	US$55.0k	0%	0.04%
0.38%	James Collins	176,130	US$49.5k	0%	no data
0.32%	Bridgeway Capital Management, LLC	145,000	US$40.7k	0%	no data
0.27%	David Epstein	123,252	US$34.6k	0%	no data
0.12%	Artal Group S.A.	55,555	US$15.6k	0%	no data
0.096%	Citadel Advisors LLC	43,703	US$12.3k	0%	no data
0.088%	BlackRock, Inc.	40,052	US$11.3k	0%	no data
0.085%	State Street Global Advisors, Inc.	39,100	US$11.0k	0%	no data
0.081%	Northern Trust Global Investments	36,848	US$10.4k	0%	no data
0.063%	Two Sigma Investments, LP	28,643	US$8.0k	0%	no data
0.047%	XTX Holdings Limited, Asset Management Arm	21,645	US$6.1k	0%	no data
0.047%	Allen Holding Inc., Asset Management Arm	21,443	US$6.0k	0%	no data
0.033%	Harbour Investments, Inc.	15,000	US$4.2k	50%	no data
0.032%	Millennium Management LLC	14,415	US$4.0k	0%	no data